Chemotherapeutic Resistance Genes of Breast Cancer Patients - An Overview

Anagha Kollamparambil Ajith ¹ , Sasikala Subramani ¹ , Agaath Hedina Manickam ¹ , Sivasamy Ramasamy ¹ *

Cited by CrossRef: 2

1- Torabian P, Yousefi H, Fallah A, Moradi Z, Naderi T, Delavar M, Ertas Y, Zarrabi A, Aref A. Cancer stem cell-mediated drug resistance: A comprehensive gene expression profile analysis in breast cancer. Pathology - Research and Practice. 2023;246:154482 [Crossref]

2- Singh S, Saini H, Sharma A, Gupta S, Huddar V, Tripathi R. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Front Oncol. 2023;13 [Crossref]

3- Guo F, Li H, Wang J, Wang J, Zhang J, Kong F, Zhang Z, Zong J. MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential. CMAR. 2024;Volume 16:1491 [Crossref]

4- Dey S, Dinakar Y, R S, Jain V, Jain R. Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells. Naunyn-Schmiedeberg's Arch Pharmacol. 2024; [Crossref]